Halipa, Jaharia .

HRN: 18-69-41  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/05/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
12/05/2025
12/12/2025
IV
4.5g
Q6
S/P Repeat LTCS; T/c Sepsis
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines